...
首页> 外文期刊>Aging & mental health >A cost effectiveness analysis of maintenance cognitive stimulation therapy (MCST) for people with dementia: examining the influence of cognitive ability and living arrangements
【24h】

A cost effectiveness analysis of maintenance cognitive stimulation therapy (MCST) for people with dementia: examining the influence of cognitive ability and living arrangements

机译:痴呆患者维持认知刺激治疗(MCST)的成本效益分析:检查认知能力和生活安排的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Identify if cost-effectiveness of Maintenance Cognitive Simulation Therapy (MCST) differs by type of living arrangement and cognitive ability of the person with dementia. Next, a value of information analysis is performed to inform decisions about future research. Methods: Incremental cost-effectiveness analysis applying seemingly unrelated regressions using data from a multicentre RCT of MCST versus treatment as usual in a population which had already received 7 weeks of CST for dementia (ISRCTN: 26286067). The findings from the cost-effectiveness analysis are used to inform a value of information analysis. Results: The results are dependent upon how quality adjusted life years (QALYs) are measured. MCST might be cost-effective compared to standard treatment for those who live alone and those with higher levels of cognitive functioning. If a further RCT was to be conducted for this sub-group of the population, value of information analysis suggests a total sample of 48 complete cases for both subgroups would be required for a two-arm trial. The expected net gain of conducting this future research is £920 million. Conclusion: Preliminary results suggest that MCST may be most cost-efficient for people with dementia who live alone and/or who have higher cognition. Future research in this area is needed.
机译:目标:确定维护认知模拟治疗的成本效益(MCST)是否因痴呆症的人的生活排列和认知能力而异。接下来,执行信息分析的价值以为未来研究的决策提供信息。方法:使用MCST与治疗的多期RCT的数据在已收到痴呆症7周(ISRCTN:26286067)的人口中,使用来自MCST与治疗的多期RCT的数据的渐进性成本效益分析从成本效益分析中的发现用于通知信息分析的价值。结果:结果取决于测量调整后的寿命(QALYS)的质量。与单独生活的人和具有更高级别认知功能的人的标准治疗相比,MCST可能具有成本效益。如果要为该人口的该小组进行进一步的RCT,则信息分析的价值表明,双臂试验需要48个次组的完整案例的总样本。进行这项未来研究的预期净收益为9.2亿英镑。结论:初步结果表明,MCST对于患有独立痴呆症和/或具有更高认知的痴呆症的人可能是最具成本效益的。需要在这一领域进行未来的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号